Skip to Content
Discovering the causes of cancer and the means of prevention

Information for Journalists

To request an interview with a DCEG investigator, contact the NCI Office of Media Relations:


Phone: 301-496-6641

Link between Aspirin Use and Lower Ovarian Cancer Risk

Posted on February 06, 2014

Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health. However, further research is needed before clinical recommendations can be made. The study was published Feb. 6, 2014, in the Journal of the National Cancer Institute. Read the full NCI press release about this study.

Reference: Trabert B, Ness RB, Lo-Ciganic WH, et al. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: A pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst 2014;106:djt431

Related Links

DCEG research on ovarian cancer

 Biography of Britton Trabert, Ph.D., M.S., Research Fellow

Biography of Nicolas Wentzensen, M.D., Ph.D., Senior Investigator